UNSPSC 85782518: Control bleeding in right lower leg, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to control bleeding in right lower leg, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0Y3H3ZZ

UNSPSC 85782518 Control bleeding in right lower leg, percutaneous approach is a Commodity code, but the recent state and local contract opportunities posted under this code show no procurement activity aligned with the code's clinical scope. The sourced opportunities instead reflect health services administration, pharmacy benefit management, virtual care platforms, peer support services, and fire department medical direction — none of which involve percutaneous bleeding-control interventions for lower extremities. The code appears to be a mismatch with the actual solicitations tagged to it in state and local procurement systems, suggesting either data classification error or administrative misalignment in how issuing bodies are applying the UNSPSC taxonomy to health services procurements.

The opportunities on record span Florida, Georgia, and California jurisdictions, including county governments (Collier County, Monroe County, and Muscogee County), a county health agency (San Mateo County Behavioral Health and Recovery Services), and a municipal fire department (Santa Monica). Recent solicitations include Columbus Consolidated Government's RFP for inmate medical and pharmacy services at Muscogee County Prison (due May 15, 2026), Collier County's RFP for pharmacy benefit management services covering 2,400 employees and 4,800 covered members (due April 9, 2026), and Monroe County's RFP for virtual primary and urgent care services covering approximately 2,300 county members (due April 16, 2026). Because the code's nominal scope bears no relation to the actual work being bought, this code shows little relevant recent activity for vendors specializing in percutaneous hemostasis devices or services.